TrialInternational urology and nephrology2021

Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial.

Osamu Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.